NEUROONE MEDICAL TECHNOLOGIE

NMTCNASDAQ

🏆 #3687 by market capEarnings Aug 13US Equity

$1.60▲ $0.04 (+2.56%)

Market closed · at close

1h—

24h▲ 2.6%

7d▼ 1.8%

14d▼ 1.8%

30d▼ 40.3%

1y▼ 66.4%

🏦Market Cap

$14M

Small Cap

📈Revenue Growth (YoY)

+11.0%

Healthy

📊Gross Margin

54.5%

Healthy

💵FCF Margin

2.0%

Thin

⚖️P/S Ratio

1.4x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $1.58 – $1.61
52-Week Range: $1.42 – $6.96
Volume: $7.15B
Avg Volume: $6.15B
Shares Outstanding: 8.7M
Next Earnings: Oct 10, 2026

Fundamentals Snapshot

Annual Revenue: $12M
Last Q Revenue: $2M
P/E Ratio: —
P/S Ratio: 1.4x
EPS (TTM): $-0.80
Dividend Yield: —

Why Investors Own NMTC

✓High-growth profile — revenue up +40.8% YoY with expanding US Equity exposure.
✓Healthy economics — 49% gross margin and 20% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$12M▲ +36.7% YoY

Gross Margin (TTM)

48.9%▲ +2.3% YoY

Operating Income (TTM)

$3M▲ +36.7% YoY

Free Cash Flow (TTM)

$2M▲ +36.7% YoY

About NEUROONE MEDICAL TECHNOLOGIE

NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.

🦦